Anti-MED6 antibody [EPR12107]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal MED6 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
ARC33, MED6, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33 kDa component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28, hMed6
- WB
Supplier Data
Western blot - Anti-MED6 antibody [EPR12107] (AB172605)
All lanes:
Western blot - Anti-MED6 antibody [EPR12107] (ab172605) at 1/1000 dilution
Lane 1:
Jurkat cell lysates at 10 µg
Lane 2:
HepG2 cell lysates at 10 µg
Predicted band size: 28 kDa
false
Related conjugates and formulations (1)
-
Anti-MED6 antibody [EPR12107] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MED6 acts as a component of the larger Mediator complex connecting transcription factors with the RNA polymerase II enzyme. This connection facilitates transcription initiation and regulation processes. The complex structure of the Mediator allows proper assembly with other essential proteins to regulate transcription effectively contributing to important cellular activities.
Pathways
The activity of the MED6 protein aligns closely with key biological pathways such as the Wnt signaling pathway and the MAPK signaling pathway. MED6 operates in concert with other Mediator complex subunits to modulate these pathways coordinating with proteins like beta-catenin in Wnt signaling and ERK proteins in MAPK signaling emphasizing its impact in cellular growth and differentiation processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Science advances 5:eaau7566 PubMed30854428
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com